Metformin and Cancer
Diabetes drug moonlights as preventative cancer treatment
By Eric Chang, diaTribe
Though metformin was first discovered in the 1920s, we are still learning about its wide-ranging effects. This learning curve will help you decipher the latest research on the potential anti-cancer effects of the well-known drug metformin.
Last June, the European medical journal Diabetologia (widely read by many European endocrinologists as well as other doctors and nurses) published a series of articles suggesting a possible link between Lantus insulin and cancer. The studies created a short-lived frenzy, but in the end a consensus soon emerged among most diabetes experts that the evidence supporting a link between Lantus insulin and cancer was too limited to draw serious conclusions. The FDA, as well as advocacy organizations such as the American Diabetes Association (ADA) and the International Diabetes Federation (IDF), published statements suggesting that findings were inconclusive and therefore patients should continue use of Lantus.
While the original focus of the Diabetologia articles was on the potential cancerous effect of a diabetes therapy, the articles did point out that a different diabetes drug, metformin, seemed to consistently have an anti-cancer effect. And while concerns about Lantus have faded away, the findings about metformin have continued to simmer. As noted by Diabetologia editor Dr. Edwin Gale (Southmead Hospital) at the 45th annual meeting of the European Association for the Study of Diabetes in Vienna last year, there was one conclusive takeaway from the ordeal: metformin, linked to a potential anti-cancer effect in the studies, should be fast tracked for further study.
Chinese Egg Drop Soup Barley, Nectarine, and Tomato Salad Northwest Grilled Flank Steak Orange-Rosemary Pork Cutlets Almond-Fudge Freeze Honey-Glazed Onions Salmon with Cucumbers and Herb Sauce Pork with Mustard Sauce Crawfish Étouffée Snow Peas with Water Chestnuts and Bamboo Shoots
As I mentioned in an earlier post, one of the benefits that made it cost-effective for me to go with the real healthcare (HSA) plan rather than the phony (HRA) plan is that my company is now covering "preventative" medicines at $0 copay. The formulary for these, as stated by CVS/Caremark (my pharmacy benefits provider), covers all test strips, lancets, and control solutions. I dutifully get my doctor to write up prescriptions for all of my testing needs, submit...